South University NSG 5003 Discussion Week 5 Assignment 1 South University NSG 5003 Discussion Week 5 Assignment 1 South University NSG 5003 Discussion Week 5 Assignment 1 South University NSG 5003 Dis

**** 5 Assignment Q1Pulmonary **** ******* ** * ******************** man *** *** *** ********* ******** *** many years ******** ** ****** *** ****** ***** ****** *********** ***** ***** CH *** the ***** **** ** ********** * physical ********** *** ********** ******** ***** ****** CH ** **** a ******** ************* ** the ***** What ** the ********** ************ process that *********** ** *** "barrel" ***** ***************** values were drawn ****** the **** ********* ****** ***** *** expect ******** ***** ** ** ****** ** ********* ******** *** ************ process involved ** **** ******** ** *** ***** ******** **** ********* *** ** **** *** **** ************* ******* ** *** ********** ******* of ***** *************** CriteriaMaximum ************* ** ******* posting395Participation ** discussion5Writing ********* ********* ******* **** *** *********** ************************ is *** ********** ************ ******* **** *********** ** the ******** ***** ************************* abnormal ********* *********** of ************ ******* (acini) *********** by *********** of ******** ***** ******* ******* ******** ******** ****** ***** With *** ** ** *** **** ** ********* ** lose ******* ****** ** *** alveoli **** **** ****** a reduction in gas exchange *** ********* increases the ****** ** *** ** the ***** Eventually the ***** **** the ******* ** meet ****** ************* hypoxemia will eventually lead to pulmonary ************ *** ***** ***** ***** ******* (Higginson ***** The barrel chest ******** ***** as *** ******* ********** and causes *** lungs ** be constantly ******** **** airLab values were ***** during the **** ********* ****** ***** you ****** ******** ***** ** be normal or ********* Arterial ***** **** vary depending of *** ***** ** *********** ** the ******* *** *********** **** show hypoxemia ******* hypercapnia ** *** **** stages of the ******* *** values **** **** *********** acidosis due ** *** airflow *********** *** the alveolar *************** *** ************ ** respiratory acidosis ** ********* and ** ******** ** ********* PCO2 *** increased ****** ************ *** ******** ***** *** analysisRisk ************* ******* ***** *** sputum production ******* susceptibility to infections ************ sided ***** failure sleep issues *** cyanosis due ** ********* ** ** ***** ************* associated **** emphysema are ********* ********* ********* lung cardiovascular ******** *** ***** * pneumothorax ***** ********* *** ** *** lungs ********** *** ******* ******** ***** can ***** and ******* *** lung ***** ******** *** ****** in ****** **** **** *** to *** damaged ******* **** damage ****** * decrease for ****** *********** ** *** body ********* *** ***** ** work ****** **** Over time **** *** put * ************ strain ** *** ***** If *** ********* **** untreated *** patient can experience ***** ************* ***** *** lead ** passing The ******* ** **** deteriorates **** each ** ***** ************* *********** ******* ** often * ***** ***** **** ***** ******** ** is important to ***** them **** and ******** to prevent ******* ******* ***** *************************** ******* ******* ** * bronchodilator (long acting ******* **** ************ *** *********** ***** ** ******** ** **** regulate ***** *** ****** ******* ** *********** COPD ******** ******** ************ ***** ******* **** *********** are ********** ** ****** the number ** ************ *********** *** **** the rate ** ******* ** quality ** **** ** **** ** forced ********** ****** ***** but **** and benefits **** be outweighed as **** *** ****** **** **** ***** ********** ********** *** pneumonia ********* Oral corticosteroids are ********** * treatment option **** *** ** helpful **** *** ******* has ********** **** *** later ****** *** ** considered * ***** ******* ****** ******* is often ******** *** ***** ******** *** **** ******** Co2 and *** ********* ****** ***** ************* antibiotics *** corticosteroids ***** ************ *** ********* *** ************ *** ********** *********** *** ** ******** ***** physiotherapy is * non-pharmacological ********* ****** ***************** ** ****** ********* *********** ******* ****** ************ *** recently ***** ******** for treatment Nutrition counseling and smoking ********* *** ******** in *** treatment **** for COPD ******** A **** ********** ***** ** indicated ** ****** cases (McCance &Huether ************ Education Besides ****** **************** *** *********** ****** **** ********* ******* ** to *** to ***** smoking again ****** ********* ***** ***** on his ** **** ****** (if ******* ****** ******** *** ********** continue his ********** regiment (anti-inflammatory **************** and ****** his ****** ** ************ **** ******* *** ********* * yearly ********* ******* *** * pneumococcal ************************ ********* ******* **** ** ********* *** patients **** **** ** **** alleviate the symptoms ** ********* previously the ********** to ***** ********* ******* *** *************** of **** with ********* demonstrate ******* ********* ****** ********* participation recognize *** ***** ******** ** COPD ********** ** ******* ********* ** breath *** ******** directives *** ** *** ** **** preparations (hospice) ****** therapy is ***** ******** *** ***** ******** *** **** ******** *** *** *** hypoxemic; ithas ***** ** ************* ******* ******** ********* **************** tailored ** *** individual patientA ************** ******** ******* ******** ******** *** ********* ******** ********* ************** ***** ********** ******* *** ******* ********* **** ***** ********** ******** ******** tolerance peak ****** ******** ********* **** ********** ******* ******** *** ********** *** *********** ****** ******** ********* symptoms **** ** ******* and ******* and ** ********* ********* ******* ******** level *** ******* ** **** Noninvasive positive ******** *********** ******* is ******* ** ******* therapy alone ** *** ******* of a ****** ************ of **** ***** ** the method ** ******** ******** ****** pressure ******* ***** to ** accessible to COPD ******** **** ****** ************* (pH less **** *** or *********** *** ****** ******** ******** ******* *********** ******* *** *************** ****** ********* ******* ** used ** ******** ********* ** some people **** ****** ********* * type ********* obstructive pulmonary ******************* ******* ***** ****** of impaired **** ****** *** ******* ** allow the ********* tissue ** ******** better After ******* ****** ***** have **** ********* ** ****** **** ****** ******* ** life *** *** ****** **** to exerciseDuring lung ****** reduction ******* * ***** ********** ******* ******* ***** ****** ** ******* **** ****** ******* ***** ** ** ** percent ** **** **** ** permit *** remaining ****** ** ******** ****** ** a ****** *** diaphragm ********* *** ******* more *********** and *********** so you *** ******* more ************* **** ***** **** **** ****** ********* ******* ******** ******** ******** lung ******** and quality of life ** ****** candidates **** ******** **** people who **** treated ******************** *** are born **** ** ********* **** ** ********* ****** ******************* deficiency-related emphysema *** *** likely ** benefit **** lung ****** ********* surgery * lung ********** *** ** * ****** treatment option **** **** volume ********* ******* *** ***** individuals **** very ******** **** **** ******** ****** *** of all ****** **** transplant ********* *** *** of ********* **** transplant ********* **** *************** ** ********** *** ** ******* ** ***** lung ************************* ** Talag MD ****** Road MD ***** Non-pharmacological ********** ** ******* *********** ********* ******* **** Vol ** No 2 March 2008 ******* 90-96 *** ***************** R ****** COPD: *************** and ************** *************** ******* ****** ****** (nd) **** Volume ********* Surgery ********* *** ** **** **** http://wwwmayoclinicorg/tests-procedures/lung-volume-reduction- What are **** ** *** ***************** ********* ******* **** *** ********* *** ******** with **** to **** ********* *** **************************************************** * (2014) Pathophysiology: The ******** Basis *** Disease ** Adults *** Children *** EditionRetrieved ***** ****************************************************************************************************** * ******* S (2014) Pathophysiology: *** ******** Basis *** Disease ** ****** and Children *** ************* *********** ********* **** ***********************************************************************

Click here to download attached files: South-University-NSG-5003-Discussion-Week-5-Assignment-1.docx